In particular, in zebrafish, DEHP exerts its obesogenic action by up-regulating hepatic pparα, cb1, and srebp levels and by stimulating de novo FA synthesis and hepatic steatosis. The gene discussed is PPARA; the disease is Hepatic steatosis.